These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 7638205

  • 1. Multimeric complexes of the PML-retinoic acid receptor alpha fusion protein in acute promyelocytic leukemia cells and interference with retinoid and peroxisome-proliferator signaling pathways.
    Jansen JH, Mahfoudi A, Rambaud S, Lavau C, Wahli W, Dejean A.
    Proc Natl Acad Sci U S A; 1995 Aug 01; 92(16):7401-5. PubMed ID: 7638205
    [Abstract] [Full Text] [Related]

  • 2. A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RAR alpha mutation.
    Shao W, Benedetti L, Lamph WW, Nervi C, Miller WH.
    Blood; 1997 Jun 15; 89(12):4282-9. PubMed ID: 9192750
    [Abstract] [Full Text] [Related]

  • 3. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
    Ahn MJ, Nason-Burchenal K, Moasser MM, Dmitrovsky E.
    Oncogene; 1995 Jun 15; 10(12):2307-14. PubMed ID: 7784078
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia.
    Grimwade D, Solomon E.
    Curr Top Microbiol Immunol; 1997 Jun 15; 220():81-112. PubMed ID: 9103677
    [Abstract] [Full Text] [Related]

  • 6. The t(5;17) acute promyelocytic leukemia fusion protein NPM-RAR interacts with co-repressor and co-activator proteins and exhibits both positive and negative transcriptional properties.
    Redner RL, Chen JD, Rush EA, Li H, Pollock SL.
    Blood; 2000 Apr 15; 95(8):2683-90. PubMed ID: 10753851
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The t(15;17) translocation in acute promyelocytic leukemia.
    Lavau C, Dejean A.
    Leukemia; 1994 Oct 15; 8(10):1615-21. PubMed ID: 7934155
    [Abstract] [Full Text] [Related]

  • 13. Detection of PML-retinoic acid receptor-alpha fusion transcripts in acute promyelocytic leukemia with trisomy 8 but without t(15;17).
    Ikeda K, Sasaki K, Tasaka T, Nagai M, Kawanishi K, Takahara J, Irino S.
    Am J Hematol; 1994 Mar 15; 45(3):212-6. PubMed ID: 8296791
    [Abstract] [Full Text] [Related]

  • 14. Differential changes of retinoid-X-receptor (RXR alpha) and its RAR alpha and PML-RAR alpha partners induced by retinoic acid and cAMP distinguish maturation sensitive and resistant t(15;17) promyelocytic leukemia NB4 cells.
    Duprez E, Lillehaug JR, Gaub MP, Lanotte M.
    Oncogene; 1996 Jun 06; 12(11):2443-50. PubMed ID: 8649786
    [Abstract] [Full Text] [Related]

  • 15. The PML-RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells.
    Rousselot P, Hardas B, Patel A, Guidez F, Gäken J, Castaigne S, Dejean A, de Thé H, Degos L, Farzaneh F.
    Oncogene; 1994 Feb 06; 9(2):545-51. PubMed ID: 8290265
    [Abstract] [Full Text] [Related]

  • 16. The molecular biology of acute promyelocytic leukemia.
    Slack JL, Gallagher RE.
    Cancer Treat Res; 1999 Feb 06; 99():75-124. PubMed ID: 9891864
    [Abstract] [Full Text] [Related]

  • 17. Characterization of the PML-RAR alpha chimeric product of the acute promyelocytic leukemia-specific t(15;17) translocation.
    Nervi C, Poindexter EC, Grignani F, Pandolfi PP, Lo Coco F, Avvisati G, Pelicci PG, Jetten AM.
    Cancer Res; 1992 Jul 01; 52(13):3687-92. PubMed ID: 1319828
    [Abstract] [Full Text] [Related]

  • 18. PMLRAR homodimers: distinct DNA binding properties and heteromeric interactions with RXR.
    Perez A, Kastner P, Sethi S, Lutz Y, Reibel C, Chambon P.
    EMBO J; 1993 Aug 01; 12(8):3171-82. PubMed ID: 8393784
    [Abstract] [Full Text] [Related]

  • 19. Variant-type PML-RAR(alpha) fusion transcript in acute promyelocytic leukemia: use of a cryptic coding sequence from intron 2 of the RAR(alpha) gene and identification of a new clinical subtype resistant to retinoic acid therapy.
    Gu BW, Xiong H, Zhou Y, Chen B, Wang L, Dong S, Yu ZY, Lu LF, Zhong M, Yin HF, Zhu GF, Huang W, Ren SX, Gallagher RE, Waxman S, Chen GQ, Wang ZG, Chen Z, Fu G, Chen SJ.
    Proc Natl Acad Sci U S A; 2002 May 28; 99(11):7640-5. PubMed ID: 12032336
    [Abstract] [Full Text] [Related]

  • 20. cAMP signalling is decisive for recovery of nuclear bodies (PODs) during maturation of RA-resistant t(15;17) promyelocytic leukemia NB4 cells expressing PML-RAR alpha.
    Duprez E, Lillehaug JR, Naoe T, Lanotte M.
    Oncogene; 1996 Jun 06; 12(11):2451-9. PubMed ID: 8649787
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.